1. Pharmacogenomics. 2015;16(9):971-9. doi: 10.2217/pgs.15.39. Epub 2015 Jun 24.

Association of SNPs with the efficacy and safety of immunosuppressant therapy 
after heart transplantation.

Sánchez-Lázaro I(1), Herrero MJ(2)(3), Jordán-De Luna C(2)(4), Bosó V(2)(4), 
Almenar L(1), Rojas L(2)(5), Martínez-Dolz L(1), Megías-Vericat JE(2)(4), Sendra 
L(3), Miguel A(3), Poveda JL(4), Aliño SF(2)(3)(6).

Author information:
(1)Unidad de Insuficiencia Cardiaca y Transplante, Servicio de Cardiología, 
Hospital Universitario y Politécnico La Fe, Av. Fernando Abril Martorell, 106, 
46026 Valencia, Spain.
(2)Unidad de Farmacogenética, Instituto Investigación Sanitaria La Fe & Área del 
Medicamento, Hospital Universitario y Politécnico La Fe, Av. Fernando Abril 
Martorell, 106, 46026 Valencia, Spain.
(3)Departamento Farmacología, Facultad de Medicina, Universidad de Valencia, Av. 
Blasco Ibáñez, 15, 46010 Valencia, Spain.
(4)Servicio de Farmacia, Área del Medicamento, Hospital Universitario y 
Politécnico La Fe, Av. Fernando Abril Martorell, 106, 46026 Valencia, Spain.
(5)Department of Internal Medicine, Faculty of Medicine, Pontificia Universidad 
Católica de Chile, Av. Libertador Bernardo O Higgins 340, Santiago, Chile.
(6)Unidad de Farmacología Clínica, Área del Medicamento, Hospital Universitario 
y Politécnico La Fe, Av. Fernando Abril Martorell, 106, 46026 Valencia, Spain.

AIM: Studying the possible influence of SNPs on efficacy and safety of 
calcineurin inhibitors upon heart transplantation.
MATERIALS & METHODS: In 60 heart transplant patients treated with tacrolimus or 
cyclosporine, we studied a panel of 36 SNPs correlated with a series of clinical 
parameters during the first post-transplantation year.
RESULTS: The presence of serious infections was correlated to ABCB1 rs1128503 (p 
= 0.012), CC genotype reduced the probability of infections being also 
associated with lower blood cyclosporine concentrations. Lower renal function 
levels were found in patients with rs9282564 AG (p = 0.003), related to higher 
blood cyclosporine blood levels. A tendency toward increased graft rejection (p 
= 0.05) was correlated to rs2066844 CC in NOD2/CARD15, a gene related to 
lymphocyte activation.
CONCLUSION: Pharmacogenetics can help identify patients at increased risk of 
clinical complications. Original submitted 30 January 2015; revision submitted 
27 March 2015.

DOI: 10.2217/pgs.15.39
PMID: 26107754 [Indexed for MEDLINE]